Literature DB >> 1824048

Predictors of response to monoamine oxidase inhibitors: do they exist?

J R Davidson1, E L Giller, S Zisook, M J Helms.   

Abstract

Multiple regression analysis was conducted on potential response predictors in a double-blind study of monoamine oxidase inhibitors (MAOI) and placebo treatment in 130 depressed outpatients. Positive main effects were found for sex (female), lack of prior hospitalization, presence of precipitating events. A negative main effect was found for concurrent physical illness. Treatment x predictor effects were found for distinct quality and non-reactivity. Non-reactivity was associated with positive outcome in the active drug group, but with negative outcome in the placebo group [corrected]. Distinct quality demonstrated a more complex effect, its presence being associated with decreased improvement in the treatment group and greater improvement in the control group. No atypical depressive symptoms predicted MAOI response, and we were unable to characterize a specifically responsive MAOI syndrome.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1824048     DOI: 10.1007/bf02219719

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  24 in total

1.  Predictors of therapeutic benefit from amitriptyline in mild depression: a general practice placebo-controlled trial.

Authors:  E S Paykel; J A Hollyman; P Freeling; P Sedgwick
Journal:  J Affect Disord       Date:  1988 Jan-Feb       Impact factor: 4.839

2.  Development of a rating scale for primary depressive illness.

Authors:  M Hamilton
Journal:  Br J Soc Clin Psychol       Date:  1967-12

3.  The influence of panic attacks on response to phenelzine and amitriptyline in depressed outpatients.

Authors:  A Kayser; D S Robinson; K Yingling; D B Howard; J Corcella; D Laux
Journal:  J Clin Psychopharmacol       Date:  1988-08       Impact factor: 3.153

4.  Responses to phenelzine and amitriptyline absence of differential predictors by multiple regression analysis.

Authors:  A V Bhat; P R Rowan; E S Paykel
Journal:  J Affect Disord       Date:  1984-04       Impact factor: 4.839

5.  Monoamine oxidase inhibitors. A review of antidepressant effectiveness.

Authors:  F Quitkin; A Rifkin; D F Klein
Journal:  Arch Gen Psychiatry       Date:  1979-07

6.  Phenelzine v imipramine in atypical depression. A preliminary report.

Authors:  M R Liebowitz; F M Quitkin; J W Stewart; P J McGrath; W Harrison; J Rabkin; E Tricamo; J S Markowitz; D F Klein
Journal:  Arch Gen Psychiatry       Date:  1984-07

7.  Research diagnostic criteria: rationale and reliability.

Authors:  R L Spitzer; J Endicott; E Robins
Journal:  Arch Gen Psychiatry       Date:  1978-06

8.  An outpatient evaluation of phenelzine and imipramine.

Authors:  J Davidson; D Raft; S Pelton
Journal:  J Clin Psychiatry       Date:  1987-04       Impact factor: 4.384

9.  An efficacy study of isocarboxazid and placebo in depression, and its relationship to depressive nosology.

Authors:  J R Davidson; E L Giller; S Zisook; J E Overall
Journal:  Arch Gen Psychiatry       Date:  1988-02

10.  A clinical trial of phenelzine in anxiety depressive and phobic neuroses.

Authors:  C Q Mountjoy; M Roth; R F Garside; I M Leitch
Journal:  Br J Psychiatry       Date:  1977-11       Impact factor: 9.319

View more
  1 in total

1.  Sex-dependent modulation of treatment response.

Authors:  David R Rubinow; Molly Moore
Journal:  Dialogues Clin Neurosci       Date:  2004-03       Impact factor: 5.986

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.